Insider Selling: Firefly Neuroscience (NASDAQ:AIFF) Major Shareholder Sells $82,410.00 in Stock

Firefly Neuroscience, Inc. (NASDAQ:AIFF) major shareholder Windsor Private Capital Lp sold 33,500 shares of the firm’s stock in a transaction on Monday, October 20th. The shares were sold at an average price of $2.46, for a total transaction of $82,410.00. Following the transaction, the insider directly owned 1,334,026 shares of the company’s stock, valued at $3,281,703.96. The trade was a 2.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Windsor Private Capital Lp also recently made the following trade(s):

• On Wednesday, October 22nd, Windsor Private Capital Lp sold 78,031 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.07, for a total transaction of $161,524.17.
• On Tuesday, October 21st, Windsor Private Capital Lp sold 19,222 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.40, for a total transaction of $46,132.80.
• On Friday, October 17th, Windsor Private Capital Lp sold 45,036 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.55, for a total transaction of $114,841.80.
• On Thursday, October 16th, Windsor Private Capital Lp sold 40,139 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.65, for a total transaction of $106,368.35.
• On Wednesday, October 15th, Windsor Private Capital Lp sold 17,500 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.74, for a total transaction of $47,950.00.
• On Tuesday, October 14th, Windsor Private Capital Lp sold 29,500 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.74, for a total transaction of $80,830.00.
• On Monday, October 13th, Windsor Private Capital Lp sold 32,136 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.65, for a total transaction of $85,160.40.
• On Friday, October 10th, Windsor Private Capital Lp sold 74,810 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.70, for a total transaction of $201,987.00.
• On Thursday, October 9th, Windsor Private Capital Lp sold 30,126 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.94, for a total transaction of $88,570.44.

Firefly Neuroscience Stock Up 1.5%

Shares of NASDAQ AIFF opened at $2.08 on Friday. Firefly Neuroscience, Inc. has a twelve month low of $1.86 and a twelve month high of $17.20. The firm has a fifty day simple moving average of $2.72 and a 200 day simple moving average of $2.94. The company has a market capitalization of $27.98 million, a PE ratio of -0.83 and a beta of 2.11.

Firefly Neuroscience (NASDAQ:AIFF) last announced its earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share for the quarter. Firefly Neuroscience had a negative return on equity of 464.02% and a negative net margin of 5,335.75%.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Friday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

Institutional Investors Weigh In On Firefly Neuroscience

A hedge fund recently raised its stake in Firefly Neuroscience stock. Geode Capital Management LLC lifted its holdings in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 120,604 shares of the company’s stock after acquiring an additional 58,067 shares during the period. Geode Capital Management LLC owned approximately 0.94% of Firefly Neuroscience worth $341,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.96% of the company’s stock.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.